Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petta

Showing results (21-30 of 833) with videos related to

Pageof 84
Sort By:
Journal of Hepatology|October 16, 2012
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients"Salvatore Petta, Antonio Craxi
BMC Infectious Diseases|November 24, 2012
Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?Salvatore Petta, Antonio Craxì
Journal of Hepatology|June 6, 2017
Coffee and tea breaks for liver healthSalvatore Petta, Giulio Marchesini
Journal of Hepatology|February 24, 2009
Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the futureCalogero Cammà, Salvatore Petta
Current Pharmaceutical Design|April 15, 2010
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular associationS Petta, A Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Optimal therapy in hepatitis C virus genotypes 2 and 3 patientsSalvatore Petta, Antonio Craxì
Hepatology (Baltimore, Md.)|June 23, 2015
ReplySalvatore Petta, Antonio Craxì
Journal of Hepatology|January 25, 2015
Epicardial fat in patients with non-alcoholic fatty liver diseaseSalvatore Petta, Antonio Craxì
Hepatology (Baltimore, Md.)|February 7, 2012
Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe?Salvatore Petta, Antonio Craxì
Journal of Chemotherapy (Florence, Italy)|July 23, 2009
Tigecycline for treatment of intra-abdominal infections: a literature updateS Esposito, E Petta
Pageof 84

Showing results (21-30 of 833) with videos related to

Sort By:
Pageof 84
Journal of Hepatology|October 16, 2012
Reply to: "IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients"Salvatore Petta, Antonio Craxi
BMC Infectious Diseases|November 24, 2012
Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat?Salvatore Petta, Antonio Craxì
Journal of Hepatology|June 6, 2017
Coffee and tea breaks for liver healthSalvatore Petta, Giulio Marchesini
Journal of Hepatology|February 24, 2009
Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the futureCalogero Cammà, Salvatore Petta
Current Pharmaceutical Design|April 15, 2010
Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular associationS Petta, A Craxì
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Optimal therapy in hepatitis C virus genotypes 2 and 3 patientsSalvatore Petta, Antonio Craxì
Hepatology (Baltimore, Md.)|June 23, 2015
ReplySalvatore Petta, Antonio Craxì
Journal of Hepatology|January 25, 2015
Epicardial fat in patients with non-alcoholic fatty liver diseaseSalvatore Petta, Antonio Craxì
Hepatology (Baltimore, Md.)|February 7, 2012
Assessment by Fibroscan of fibrosis in nonalcoholic fatty liver disease: XL versus M probe?Salvatore Petta, Antonio Craxì
Journal of Chemotherapy (Florence, Italy)|July 23, 2009
Tigecycline for treatment of intra-abdominal infections: a literature updateS Esposito, E Petta
Pageof 84